Skip to main content
Premium Trial:

Request an Annual Quote

Asper Biotech

Premium
Asper Biotech launched two arrays this month. The first is a chip for screening six genes connected with hereditary breast and ovarian cancer.
 
The company said the array enables users to analyze 88 mutations in the BRCA1, BRCA2, CHEK2, RAD51, NBN, and CASP8 genes.
 

Asper also launched an array for Wilson disease screening that assays 104 mutations in the ATP7B gene. The Wilson disease chip was developed and validated with the University of Brno in the Czech Republic, Asper said.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.